{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:51:32Z","timestamp":1791229892238,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2495,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Excessive weight gain, hypertension, hyperlipidemia, and diabetes are frequently observed in patients having undergone liver transplantation (LTx). These alterations are probably multifactorial in origin, and cluster to generate a metabolic syndrome (MS), increasing the risk of cardiovascular events. We assessed the prevalence of MS (National Cholesterol Education Program-Adult Treatment Panel III criteria) in 296 LTx patients in the course of regular follow-up, at least 6 months after transplantation (median, 38 months). Several pre-LTx and post-LTx data were collected to identify the factors associated with the presence of MS. In a subset of 99 patients, insulin resistance was measured by the homeostasis model assessment. High blood pressure was present in 53% of cases, hyperlipidemia in 51%, high glucose in 37%, and enlarged waist circumference in 32%. Overall, MS (defined as 3 or more of the above features) was present in 44.5% of cases. Insulin resistance (homeostasis model assessment &gt; 2.7) was observed in 41% of cases. Hypertension and hyperlipidemia were more frequent in subjects on cyclosporine than in tacrolimus-treated cases, whereas the type of immunosuppressive drug had no effect on the prevalence of diabetes, enlarged waist, and MS. In a logistic regression analysis, only pre-LTx body mass index (odds ratio, 1.20), body mass index increase (odds ratio, 1.18), and pre-LTx diabetes (odds ratio, 2.36) predicted MS; age, gender, etiology of liver disease, time from LTx, type of immunosuppressive drug, and previous hepatocellular carcinoma were removed from the model. Disorders related to MS are frequent in LTx patients, and are related to both pre-LTx conditions and to weight gain. Weight control is mandatory in LTx patients to prevent risk factors of premature atherosclerosis. Liver Transpl 14: 1648\u20131654, 2008. \u00a9 2008 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.21588","type":"journal-article","created":{"date-parts":[[2008,10,29]],"date-time":"2008-10-29T13:26:13Z","timestamp":1225286773000},"page":"1648-1654","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":218,"title":["Metabolic syndrome in liver transplantation: Relation to etiology and immunosuppression"],"prefix":"10.1097","volume":"14","author":[{"given":"Giampaolo","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Marchesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Marzocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio D.","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20250326","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1600-6143.2006.01256.x","article-title":"No improvement in longterm liver transplant graft survival in the last decade: an analysis of the UNOS data.","volume":"6","author":"Futagawa","year":"2006","journal-title":"Am J Transplant"},{"key":"R2-17-20250326","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hep.510310320","article-title":"Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation.","volume":"31","author":"Perseghin","year":"2000","journal-title":"Hepatology"},{"key":"R3-17-20250326","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1432-2277.2004.00067.x","article-title":"Weight gain and obesity after liver transplantation.","volume":"18","author":"Richards","year":"2005","journal-title":"Transpl Int"},{"key":"R4-17-20250326","first-page":"1289","article-title":"Posttransplant diabetes mellitusa review.","volume":"58","author":"Jindal","year":"1994","journal-title":"Transplantation"},{"key":"R5-17-20250326","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.21126","article-title":"Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.","volume":"13","author":"Laryea","year":"2007","journal-title":"Liver Transpl"},{"key":"R6-17-20250326","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00042737-200301000-00018","article-title":"Recurrence of insulin resistant metabolic syndrome following liver transplantation.","volume":"15","author":"Angelico","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R7-17-20250326","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/jlts.2001.24644","article-title":"Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.","volume":"7","author":"Ong","year":"2001","journal-title":"Liver Transpl"},{"key":"R8-17-20250326","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1573399052952604","article-title":"Newonset posttransplantation diabetes mellitus: insulin resistance or insulinopenia?","volume":"1","author":"Hjelmesaeth","year":"2005","journal-title":"Curr Diab Rev"},{"key":"R9-17-20250326","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF03343761","article-title":"The metabolic effects of cyclosporin and tacrolimus.","volume":"23","author":"Marchetti","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"R10-17-20250326","first-page":"928","article-title":"Influence of obesity with concurrent diseases on liver transplant survival.","volume":"13","author":"Perkins","year":"2007","journal-title":"Liver Transpl"},{"key":"R11-17-20250326","first-page":"485","article-title":"Metabolic syndrome: a new view of some familiar transplant risks.","volume":"12","author":"Perkins","year":"2006","journal-title":"Liver Transpl"},{"key":"R12-17-20250326","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1111\/j.1600-6143.2005.01104.x","article-title":"Oneyear posttransplant weight gain is a risk factor for graft loss.","volume":"5","author":"Ducloux","year":"2005","journal-title":"Am J Transplant"},{"key":"R13-17-20250326","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and betacell function from plasma fasting glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R14-17-20250326","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jc.2004-2240","article-title":"Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.","volume":"90","author":"Bugianesi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-17-20250326","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R16-17-20250326","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart AssociationNational Heart, Lung, and Blood Institute Scientific Statement.","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R17-17-20250326","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00007890-200109270-00015","article-title":"Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality.","volume":"72","author":"Baid","year":"2001","journal-title":"Transplantation"},{"key":"R18-17-20250326","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jhep.2000.8270","article-title":"Hepatitis Crelated cirrhosis: a predictor of diabetes after liver transplantation.","volume":"32","author":"Bigam","year":"2000","journal-title":"Hepatology"},{"key":"R19-17-20250326","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/lt.20092","article-title":"New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.","volume":"10","author":"Khalili","year":"2004","journal-title":"Liver Transpl"},{"key":"R20-17-20250326","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"key":"R21-17-20250326","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"R22-17-20250326","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0168-8278(01)00143-X","article-title":"Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.","volume":"35","author":"Petit","year":"2001","journal-title":"J Hepatol"},{"key":"R23-17-20250326","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diacare.25.3.583","article-title":"Posttransplantation diabetes: a systematic review of the literature.","volume":"25","author":"Montori","year":"2002","journal-title":"Diabetes Care"},{"key":"R24-17-20250326","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.transproceed.2006.02.060","article-title":"The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.","volume":"38","author":"Mindikoglu","year":"2006","journal-title":"Transplant Proc"},{"key":"R25-17-20250326","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndromea new worldwide definition.","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"R26-17-20250326","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.numecd.2004.09.002","article-title":"Prevalence of the metabolic syndrome among Italian adults according to ATP III definition.","volume":"15","author":"Miccoli","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R27-17-20250326","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/lt.21096","article-title":"Metabolic syndrome following liver transplantation is associated with major vascular events.","volume":"13","author":"Liangpunsakul","year":"2007","journal-title":"Liver Transpl"},{"key":"R28-17-20250326","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-2007-978954","article-title":"Mechanism of the diabetogenic action of cyclosporin A.","volume":"30","author":"Menegazzo","year":"1998","journal-title":"Horm Metab Res"},{"key":"R29-17-20250326","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1600-6143.2003.00372.x","article-title":"New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and metaanalysis.","volume":"4","author":"Heisel","year":"2004","journal-title":"Am J Transplant"},{"key":"R30-17-20250326","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.transproceed.2004.12.017","article-title":"Prospective, multicenter, randomized trial to compare incidence of newonset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation.","volume":"37","author":"Vincenti","year":"2005","journal-title":"Transplant Proc"},{"key":"R31-17-20250326","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1681\/ASN.V131213","article-title":"Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporinebased immunosuppression.","volume":"13","author":"van Duijnhoven","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R32-17-20250326","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/01.tp.0000267647.03550.22","article-title":"The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients.","volume":"84","author":"DavidNeto","year":"2007","journal-title":"Transplantation"},{"key":"R33-17-20250326","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1210\/en.2003-1152","article-title":"Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulussecretion coupling.","volume":"145","author":"Uchizono","year":"2004","journal-title":"Endocrinology"},{"key":"R34-17-20250326","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0041-1345(03)00528-1","article-title":"Diabetes mellitus after liver transplant new etiologic clues and cornerstones for understanding.","volume":"35","author":"Tueche","year":"2003","journal-title":"Transplant Proc"},{"key":"R35-17-20250326","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/lt.20586","article-title":"Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation.","volume":"12","author":"Bianchi","year":"2006","journal-title":"Liver Transpl"},{"key":"R36-17-20250326","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.metabol.2006.03.010","article-title":"Associations between serum insulin and homocysteine in a Swedish populationa potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project.","volume":"55","author":"Bjorck","year":"2006","journal-title":"Metabolism"},{"key":"R37-17-20250326","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1464-5491.2006.01950.x","article-title":"Coronary calcification, homocysteine, Creactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study.","volume":"23","author":"Godsland","year":"2006","journal-title":"Diabet Med"},{"key":"R38-17-20250326","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/hrt.2006.093971","article-title":"Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome.","volume":"93","author":"Hajer","year":"2007","journal-title":"Heart"},{"key":"R39-17-20250326","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.atherosclerosis.2007.01.019","article-title":"Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham Risk Score.","volume":"196","author":"Junyent","year":"2008","journal-title":"Atherosclerosis"},{"key":"R40-17-20250326","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1600-6143.2004.00432.x","article-title":"Nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and orthotopic liver transplantation.","volume":"4","author":"Burke","year":"2004","journal-title":"Am J Transplant"},{"key":"R41-17-20250326","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amjmed.2007.08.041","article-title":"Carotid artery intimamedia thickness in nonalcoholic fatty liver disease.","volume":"121","author":"Fracanzani","year":"2008","journal-title":"Am J Med"},{"key":"R42-17-20250326","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/jlts.2001.23011","article-title":"Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.","volume":"7","author":"Contos","year":"2001","journal-title":"Liver Transpl"},{"key":"R43-17-20250326","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1053\/jlts.2003.50165","article-title":"An evaluation of longterm outcomes after liver transplantation for cryptogenic cirrhosis.","volume":"9","author":"Heneghan","year":"2003","journal-title":"Liver Transpl"},{"key":"R44-17-20250326","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1002\/lt.20602","article-title":"Cardiovascular risk factors after liver transplantation.","volume":"11","author":"Munoz","year":"2005","journal-title":"Liver Transpl"},{"key":"R45-17-20250326","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1600-6143.2006.01391.x","article-title":"A randomized trial of exercise and dietary counseling after liver transplantation.","volume":"6","author":"Krasnoff","year":"2006","journal-title":"Am J Transplant"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21588","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200811000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T19:07:32Z","timestamp":1743275252000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200811000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.21588","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}